Global POC Infectious Diseases Market Research Report 2019

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by POC Infectious Diseases Revenue
• 1.4 Market by Type
  • 1.4.1 Global POC Infectious Diseases Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Flu
  • 1.4.3 Adenovirus
  • 1.4.4 Malaria
  • 1.4.5 Streptococcal Bacteremia
  • 1.4.6 Tuberculosis (TB)
  • 1.4.7 Occult Blood
  • 1.4.8 HIV
• 1.5 Market by Application
  • 1.5.1 Global POC Infectious Diseases Market Share by Application: 2020 VS 2026
  • 1.5.2 Hospital& Clinics
  • 1.5.3 Clinical Diagnostic Laboratories
  • 1.5.4 Homecare Settings
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global POC Infectious Diseases Market Perspective (2015-2026)
• 2.2 Global POC Infectious Diseases Growth Trends by Regions
  • 2.2.1 POC Infectious Diseases Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 POC Infectious Diseases Historic Market Share by Regions (2015-2020)
  • 2.2.3 POC Infectious Diseases Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 POC Infectious Diseases Market Growth Strategy
  • 2.3.6 Primary Interviews with Key POC Infectious Diseases Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top POC Infectious Diseases Players by Market Size
  • 3.1.1 Global Top POC Infectious Diseases Players by Revenue (2015-2020)
  • 3.1.2 Global POC Infectious Diseases Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global POC Infectious Diseases Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global POC Infectious Diseases Market Concentration Ratio
  • 3.2.1 Global POC Infectious Diseases Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by POC Infectious Diseases Revenue in 2019
• 3.3 POC Infectious Diseases Key Players Head office and Area Served
• 3.4 Key Players POC Infectious Diseases Product Solution and Service
• 3.5 Date of Enter into POC Infectious Diseases Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global POC Infectious Diseases Historic Market Size by Type (2015-2020)
• 4.2 Global POC Infectious Diseases Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

• 5.1 Global POC Infectious Diseases Market Size by Application (2015-2020)
• 5.2 Global POC Infectious Diseases Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America POC Infectious Diseases Market Size (2015-2020)
• 6.2 POC Infectious Diseases Key Players in North America (2019-2020)
• 6.3 North America POC Infectious Diseases Market Size by Type (2015-2020)
• 6.4 North America POC Infectious Diseases Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe POC Infectious Diseases Market Size (2015-2020)
• 7.2 POC Infectious Diseases Key Players in Europe (2019-2020)
• 7.3 Europe POC Infectious Diseases Market Size by Type (2015-2020)
• 7.4 Europe POC Infectious Diseases Market Size by Application (2015-2020)

8 China

• 8.1 China POC Infectious Diseases Market Size (2015-2020)
• 8.2 POC Infectious Diseases Key Players in China (2019-2020)
• 8.3 China POC Infectious Diseases Market Size by Type (2015-2020)
• 8.4 China POC Infectious Diseases Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan POC Infectious Diseases Market Size (2015-2020)
• 9.2 POC Infectious Diseases Key Players in Japan (2019-2020)
• 9.3 Japan POC Infectious Diseases Market Size by Type (2015-2020)
• 9.4 Japan POC Infectious Diseases Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia POC Infectious Diseases Market Size (2015-2020)
• 10.2 POC Infectious Diseases Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia POC Infectious Diseases Market Size by Type (2015-2020)
• 10.4 Southeast Asia POC Infectious Diseases Market Size by Application (2015-2020)

11 India

• 11.1 India POC Infectious Diseases Market Size (2015-2020)
• 11.2 POC Infectious Diseases Key Players in India (2019-2020)
• 11.3 India POC Infectious Diseases Market Size by Type (2015-2020)
• 11.4 India POC Infectious Diseases Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America POC Infectious Diseases Market Size (2015-2020)
• 12.2 POC Infectious Diseases Key Players in Central & South America (2019-2020)
• 12.3 Central & South America POC Infectious Diseases Market Size by Type (2015-2020)
• 12.4 Central & South America POC Infectious Diseases Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Abbott
  • 13.1.1 Abbott Company Details
  • 13.1.2 Abbott Business Overview
  • 13.1.3 Abbott POC Infectious Diseases Introduction
  • 13.1.4 Abbott Revenue in POC Infectious Diseases Business (2015-2020))
  • 13.1.5 Abbott Recent Development
• 13.2 Meridian Bioscience
  • 13.2.1 Meridian Bioscience Company Details
  • 13.2.2 Meridian Bioscience Business Overview
  • 13.2.3 Meridian Bioscience POC Infectious Diseases Introduction
  • 13.2.4 Meridian Bioscience Revenue in POC Infectious Diseases Business (2015-2020)
  • 13.2.5 Meridian Bioscience Recent Development
• 13.3 Orasure Technologies
  • 13.3.1 Orasure Technologies Company Details
  • 13.3.2 Orasure Technologies Business Overview
  • 13.3.3 Orasure Technologies POC Infectious Diseases Introduction
  • 13.3.4 Orasure Technologies Revenue in POC Infectious Diseases Business (2015-2020)
  • 13.3.5 Orasure Technologies Recent Development
• 13.4 Trinity Biotech
  • 13.4.1 Trinity Biotech Company Details
  • 13.4.2 Trinity Biotech Business Overview
  • 13.4.3 Trinity Biotech POC Infectious Diseases Introduction
  • 13.4.4 Trinity Biotech Revenue in POC Infectious Diseases Business (2015-2020)
  • 13.4.5 Trinity Biotech Recent Development
• 13.5 Abbott
  • 13.5.1 Abbott Company Details
  • 13.5.2 Abbott Business Overview
  • 13.5.3 Abbott POC Infectious Diseases Introduction
  • 13.5.4 Abbott Revenue in POC Infectious Diseases Business (2015-2020)
  • 13.5.5 Abbott Recent Development
• 13.6 Beckman Coulter/ Danaher
  • 13.6.1 Beckman Coulter/ Danaher Company Details
  • 13.6.2 Beckman Coulter/ Danaher Business Overview
  • 13.6.3 Beckman Coulter/ Danaher POC Infectious Diseases Introduction
  • 13.6.4 Beckman Coulter/ Danaher Revenue in POC Infectious Diseases Business (2015-2020)
  • 13.6.5 Beckman Coulter/ Danaher Recent Development
• 13.7 Becton Dickinson
  • 13.7.1 Becton Dickinson Company Details
  • 13.7.2 Becton Dickinson Business Overview
  • 13.7.3 Becton Dickinson POC Infectious Diseases Introduction
  • 13.7.4 Becton Dickinson Revenue in POC Infectious Diseases Business (2015-2020)
  • 13.7.5 Becton Dickinson Recent Development
• 13.8 Biomerieux
  • 13.8.1 Biomerieux Company Details
  • 13.8.2 Biomerieux Business Overview
  • 13.8.3 Biomerieux POC Infectious Diseases Introduction
  • 13.8.4 Biomerieux Revenue in POC Infectious Diseases Business (2015-2020)
  • 13.8.5 Biomerieux Recent Development
• 13.9 Bio-Rad
  • 13.9.1 Bio-Rad Company Details
  • 13.9.2 Bio-Rad Business Overview
  • 13.9.3 Bio-Rad POC Infectious Diseases Introduction
  • 13.9.4 Bio-Rad Revenue in POC Infectious Diseases Business (2015-2020)
  • 13.9.5 Bio-Rad Recent Development
• 13.10 Cepheid
  • 13.10.1 Cepheid Company Details
  • 13.10.2 Cepheid Business Overview
  • 13.10.3 Cepheid POC Infectious Diseases Introduction
  • 13.10.4 Cepheid Revenue in POC Infectious Diseases Business (2015-2020)
  • 13.10.5 Cepheid Recent Development
• 13.11 Diamedix
  • 10.11.1 Diamedix Company Details
  • 10.11.2 Diamedix Business Overview
  • 10.11.3 Diamedix POC Infectious Diseases Introduction
  • 10.11.4 Diamedix Revenue in POC Infectious Diseases Business (2015-2020)
  • 10.11.5 Diamedix Recent Development
• 13.12 Diasorin
  • 10.12.1 Diasorin Company Details
  • 10.12.2 Diasorin Business Overview
  • 10.12.3 Diasorin POC Infectious Diseases Introduction
  • 10.12.4 Diasorin Revenue in POC Infectious Diseases Business (2015-2020)
  • 10.12.5 Diasorin Recent Development
• 13.13 Eiken Chemical
  • 10.13.1 Eiken Chemical Company Details
  • 10.13.2 Eiken Chemical Business Overview
  • 10.13.3 Eiken Chemical POC Infectious Diseases Introduction
  • 10.13.4 Eiken Chemical Revenue in POC Infectious Diseases Business (2015-2020)
  • 10.13.5 Eiken Chemical Recent Development
• 13.14 Enzo Biochem
  • 10.14.1 Enzo Biochem Company Details
  • 10.14.2 Enzo Biochem Business Overview
  • 10.14.3 Enzo Biochem POC Infectious Diseases Introduction
  • 10.14.4 Enzo Biochem Revenue in POC Infectious Diseases Business (2015-2020)
  • 10.14.5 Enzo Biochem Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer